BridgeMD
Tests treatment safety and results for Acute Treatment of Migraine
Official title A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
ClinicalTrials.gov ID: NCT07609914
What this study is testing
What is Rimegepant?
Rimegepant is an investigational medicine, being studied as a potential treatment for acute treatment of migraine.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Acute treatments for migraine may not provide sufficient pain relief after an initial dose, and a second dose of a given medication may be needed to fully abort an attack. International Headache Society (IHS) global practice recommendations for the Acute Treatment of Migraine suggest a second dose of the same medication within the recommended dose limit in people with headache relapse after successful initial treatment of a migraine attack.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Inclusion:
- Eligible participants include adult participants aged 18 years of age or older with a minimum 1-year history of migraine (with or without aura)...
- Eligible participants must be currently using acute migraine treatment in accordance with the local label and have all of the following on average...
- Participants with headaches occurring ≥15 days per month (migraine or non-migraine) on average across the 12 weeks prior to the Screening Visit and...
The study team makes the final eligibility decision.
Where it's taking place
- Canoga Park, California, United States
- Boca Raton, Florida, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Worcester, Massachusetts, United States
- Ann Arbor, Michigan, United States
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canoga Park, California, United States; Boca Raton, Florida, United States; Miami, Florida, United States; Orlando, Florida, United States; Worcester, Massachusetts, United States; Ann Arbor, Michigan, United States and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.